Dr. Pavlos Msaouel
Claim this profileM D Anderson Cancer Center
Studies Renal Cell Carcinoma
Studies Kidney Cancer
6 reported clinical trials
11 drugs studied
Area of expertise
1Renal Cell Carcinoma
Stage IV
SMARCB1 negative
Stage III
2Kidney Cancer
Stage IV
SMARCB1 negative
Stage III
Affiliated Hospitals
Clinical Trials Pavlos Msaouel is currently running
Triple Drug Therapy
for Kidney Cancer
This phase II trial studies the effects of combination therapy with bevacizumab, erlotinib, and atezolizumab in treating patients with hereditary leiomyomatosis and kidney cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Bevacizumab is in a class of medications called antiangiogenic agents. They work by stopping the formation of blood vessels that bring oxygen and nutrients to tumors. This may slow the growth and spread of tumors. Erlotinib is in a class of medications called kinase inhibitors. It works by blocking the action of a protein called EGFR that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Combination therapy with bevacizumab, erlotinib, and atezolizumab may stabilize or shrink advanced hereditary leiomyomatosis and kidney cancer.
Recruiting1 award Phase 218 criteria
Ubamatamab + Cemiplimab
for Tumors
To find out if ubamatamab, given by itself or in combination with cemiplimab, can help to control the disease in participants with renal medullary carcinoma (RMC) and epithelioid sarcoma (ES).
Recruiting1 award Phase 26 criteria
More about Pavlos Msaouel
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Pavlos Msaouel has experience with
- Nivolumab
- Sitravatinib
- Cemiplimab
- Ubamatamab
- Doxorubicin
- Gemcitabine
Breakdown of trials Pavlos Msaouel has run
Renal Cell Carcinoma
Kidney Cancer
Rhabdoid Tumor
Kidney Carcinoma
Malignant Rhabdoid Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pavlos Msaouel specialize in?
Pavlos Msaouel focuses on Renal Cell Carcinoma and Kidney Cancer. In particular, much of their work with Renal Cell Carcinoma has involved Stage IV patients, or patients who are SMARCB1 negative.
Is Pavlos Msaouel currently recruiting for clinical trials?
Yes, Pavlos Msaouel is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Pavlos Msaouel has studied deeply?
Yes, Pavlos Msaouel has studied treatments such as Nivolumab, Sitravatinib, Cemiplimab.
What is the best way to schedule an appointment with Pavlos Msaouel?
Apply for one of the trials that Pavlos Msaouel is conducting.
What is the office address of Pavlos Msaouel?
The office of Pavlos Msaouel is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.